New research reveals how fluoxetine boosts immune protection and prevents sepsis-related heart and metabolic damage.
The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...
This Research Topic is the second volume of the Research Topic Outcome of Sepsis and Prediction of Mortality RiskSepsis is a life-threatening condition due ...
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
The following is a summary of “Ability to return to work and persistent symptoms six months after viral meningitis – a ...
The following is a summary of “Hospital readmission after surviving sepsis: A systematic review of readmission reasons and meta-analysis of readmission rates,” published in the February 2025 issue of ...
A systematic review assessed compliance or implementation of the Centers for Medicare & Medicaid Services (CMS) Severe Sepsis and Septic Shock Management Bundle (SEP-1) and its association with sepsis ...
Drugs that can prevent or relieve migraine attacks are only effective for some people. Research is starting to untangle the ...
In this systematic review, there was minimal evidence of improved sepsis mortality with implementation of the Severe Sepsis ...
A programme that tracks and monitors infectious diseases across the country has seen a steady rise in certain disease cases ...
Upon arriving in hospital the 22-year-old waited 90 minutes to be given antibiotics despite his mum's desperate pleas.
SHA, the Athabasca Health Authority and the Northern Inter-Tribal Health Authority are warning about an outbreak of strep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results